Literature DB >> 21790925

Anaemia is highly prevalent among unselected internal medicine inpatients and is associated with increased mortality, earlier readmission and more prolonged hospital stay: an observational retrospective cohort study.

R L Nathavitharana1, J A Murray, N D'Sousa, T Sheehan, C M Frampton, B W Baker.   

Abstract

BACKGROUND: Anaemia is associated with adverse outcomes in elderly community-dwelling individuals, but this problem is less well characterised in the inpatient setting. AIMS: To determine the prevalence of anaemia and its associations in a well-defined cohort of internal medicine inpatients.
METHODS: A retrospective cohort study of non-elective admissions under internal medicine at Palmerston North Hospital, New Zealand, was conducted for 4 months of 2008 with outcome analysis on 1 March 2010.
RESULTS: At admission, 497 of 1491 (33.3%) patients were anaemic by World Health Organization criteria (haemoglobin <130 g/L for males; <120 g/L for females). Anaemia was more prevalent in males (38.1%) than females (28.2%), P < 0.001, in patients aged 65 years or older (41%) than in those under 65 (21.3%), P < 0.001, in New Zealand Europeans (34.3%) than in Māori and people from the Pacific Islands (26.4%), P= 0.04, and in patients admitted primarily because of malignancy, endocrine/metabolic disease, infection, and acute coronary syndrome/congestive heart failure (P < 0.001). Anaemia was independently associated with increased length of hospital stay (7.3 days vs 5.1 days in non-anaemic patients; P < 0.001), with mortality (P < 0.001) and unplanned hospital readmission (P < 0.001) during the follow-up period. Anaemia was infrequently acknowledged or investigated. Secondary analysis using a haemoglobin threshold of 110 g/L showed similar results.
CONCLUSIONS: Anaemia is highly prevalent among medical inpatients with variation because of gender, age, race and reason for admission. Anaemia independently predicts for prolonged hospital stay, increased mortality and shorter time to readmission, but is usually not documented or investigated in this setting.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2012        PMID: 21790925     DOI: 10.1111/j.1445-5994.2011.02566.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  6 in total

1.  Anemia in elderly hospitalized patients: prevalence and clinical impact.

Authors:  Margherita Migone De Amicis; Erika Poggiali; Irene Motta; Francesca Minonzio; Giovanna Fabio; Cinzia Hu; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2015-01-30       Impact factor: 3.397

2.  Extremely Old Patients Hospitalized in Internal Medicine: What about Their Anemia?

Authors:  Maria Luigia Randi; Irene Bertozzi; Claudia Santarossa; Fabrizio Lucente; Giacomo Biagetti; Fabrizio Fabris
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-05-01       Impact factor: 2.576

3.  Anemia management: development of a rapidaccess anemia and intravenous iron service.

Authors:  Deepti Radia; Ibrahim Momoh; Richard Dillon; Yvonne Francis; Laura Cameron; Toni-Lee Fagg; Hannah Overland; Susan Robinson; Claire N Harrison
Journal:  Risk Manag Healthc Policy       Date:  2013-08-06

4.  Orthostatic hypotension among elderly patients in Italian internal medicine wards: an observational study-comment.

Authors:  Hatice Bolek; Ertugrul Cagri Bolek
Journal:  Intern Emerg Med       Date:  2020-07-18       Impact factor: 3.397

5.  Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome.

Authors:  Maria Luigia Randi; Irene Bertozzi; Claudia Santarossa; Elisabetta Cosi; Fabrizio Lucente; Giulia Bogoni; Giacomo Biagetti; Fabrizio Fabris
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

Review 6.  Ultrasound as First Line Step in Anaemia Diagnostics.

Authors:  Chiara Mozzini; Giancarlo Pesce; Alder Casadei; Domenico Girelli; Maurizio Soresi
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-11-01       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.